Regular Monitoring of Cytomegalovirus (CMV)-specific Cell-Mediated Immunity in Intermediate-Risk Kidney Transplant Recipients: Predictive Value of the Immediate Post-Transplant Assessment.

Clinical Microbiology and Infection - United Kingdom
doi 10.1016/j.cmi.2018.05.010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Association Between Post-Transplant Red Cell Distribution Width and Prognosis of Kidney Transplant Recipients

Scientific Reports
Multidisciplinary
2017English

Management of Cytomegalovirus (CMV) in Hematopoietic Stem Cell Transplant (HSCT)

Journal of Pediatrics & Neonatal Care
2014English

High Mortality of CMV Pneumonia in Hematopietic Cell Transplant Recipients.

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Testing QOL Causal Model of Kidney Post-Transplant Recipients

Journal of Japan Academy of Nursing Science
1998English

Cytomegalovirus Infection Among Kidney Transplant Recipients One Year After Transplantation

journal of ilam university of medical sciences
2018English

Pre and Post Transplant Cytomegalovirus (CMV) Infection and Successful Graft Survival

International Journal of Human Genetics
Genetics
2012English

Cancer Risk Following Post-Transplant Lymphoproliferative Disorders in Solid Organ Transplant Recipients

British Journal of Haematology
Hematology
2019English

Where the Chromosome Ends: Telomeres and CMV Risk in Lung Transplant Recipients

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy